Keep up with everything going on in the pulmonary hypertension community with news, stories, events, educational information and ways to get involved.
Thursday, August 8, 2013
PHA President on New Drug for PAH & CTEPH
PHA President on New Drug for PAH & CTEPH PHA's President Rino Aldrighetti was at the meeting earlier this week where a FDA committee reviewed a possible new drug for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Read Rino's blog for a front row seat